Navigation Links
Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
Date:2/22/2013

ctations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding Meda's prior experience with flupirtine and its impact on U.S. regulatory approval. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Synthetic Biologics' forward-looking statements include, among others, a failure to achieve regulatory approval  and other factors described in Synthetic Biologics' report on Form 10-K/A for the year ended December 31, 2011 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Synthetic Biologics undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.


'/>"/>
SOURCE Synthetic Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inovios Synthetic Flu Vaccine Doubles Rate of Elderly Subjects Displaying Protective Immune Responses
2. Synthetic Biologics Closes Deal for Acquisition of C. difficile Infectious Disease Program
3. Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
4. The Use of New Replikins Synthetic Vaccines to Prevent Pandemics to be Presented at Influenza Congress Nov. 12 in Washington DC
5. Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections
6. Synthetic Biologics Reports Second Quarter 2012 Financial Results
7. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
8. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
9. Employers Becoming Savvier About Biologics and Specialty Drugs
10. Pinnacle Biologics beantragt Zulassung neuer Indikationen in Deutschland und Frankreich
11. Pinnacle Biologics dépose une nouvelle indication pharmaceutique en Allemagne et en France
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014   Auxilium Pharmaceuticals , Inc. (NASDAQ: ... company, today announced that the Company will release results ... 7, 2014 before the opening of the U.S. financial ... that day at 8:30 a.m. ET to discuss results ... presentation slides to be used during the call will ...
(Date:7/31/2014)... , July 31, 2014  Decision ... changes brought about by the Affordable Care ... and prescribing of pharmaceutical therapies. The ACA ... beneficiaries through new regulations and expanded access ... in the health exchanges—state-based marketplaces set up ...
(Date:7/31/2014)... 2014 Touro University California,s College of Pharmacy ... the recipient of a $150,000 grant by the Joseph ... to increase research and classroom space on its campus. ... the study of health sciences, and will help us ... interests of our students," said Shelley Berkley , ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Touro University California Garners Grant From Long Foundation 2
... -- Global Information, Inc. (GII) presents " Computed Tomography ... Market Forecasts to 2017 " by GlobalData.  ... global Computed Tomography (CT) systems market to be worth ... systems and low-dose CT systems, the market is forecast ...
... -- Physicians, Capital Investments, LLC (PCI/the Company) a leader ... is pleased to announce that Becker,s ASC Review has ... in the ASC Industry to Know." This publication recognizes ... through their work with ASC-related companies, surgery centers and ...
Cached Medicine Technology:GiiResearch.com: Computed Tomography (CT) Systems - Technological Advances and Positive Clinical Trial Evidences to Drive the Market 2GiiResearch.com: Computed Tomography (CT) Systems - Technological Advances and Positive Clinical Trial Evidences to Drive the Market 3GiiResearch.com: Computed Tomography (CT) Systems - Technological Advances and Positive Clinical Trial Evidences to Drive the Market 4Physicians' Capital Investments Announces Pedro Vergne-Marini, MD Named to Becker's ASC Review "350 People in the ASC Industry to Know" 2Physicians' Capital Investments Announces Pedro Vergne-Marini, MD Named to Becker's ASC Review "350 People in the ASC Industry to Know" 3Physicians' Capital Investments Announces Pedro Vergne-Marini, MD Named to Becker's ASC Review "350 People in the ASC Industry to Know" 4
(Date:8/1/2014)... at the Institute of Bioengineering and Nanotechnology (IBN), ... Singapore (NCCS) have co-developed the first molecular test ... in kidney cancer patients. This breakthrough was recently ... top urology journal. , According to IBN ... our expertise in molecular diagnostics and cancer research, ...
(Date:8/1/2014)... St. Christopher's Hospital for Children announced that they ... with Ed Begley Jr, airing later this year 2014, ... St. Christopher's Hospital for Children offers a wide range ... 21 years of age. With over 220 pediatric specialists, ... autism and childhood obesity. , “St. Christopher’s is ...
(Date:8/1/2014)... Jordan, Utah (PRWEB) August 01, 2014 ... company MonaVie, who completes its 500th week of paying ... since the company was founded in January 2005 total ... countries throughout the world. The company pays commissions in ... HUF, ILS, JPY, MYR, MXN, NZD, PLN, USD, SGD, ...
(Date:8/1/2014)... BellasDress has recently showcased its beautifully ... season’s gorgeous styles. The company’s lot of hot styles, ... outfits, one shoulder chiffon outfits and high low outfits. ... elegant purple prom dresses. As one of the most ... product quality. Thus, all its items are of superb ...
(Date:8/1/2014)... CentraComm, a leading managed IT security ... the Pure Storage® Authorized Reseller program. , ... experience designed to meet the rigorous resiliency, scalability, ... diverse markets, and for a variety of high ... years. , The Pure Storage FlashArray was ...
Breaking Medicine News(10 mins):Health News:Taking the guesswork out of cancer therapy 2Health News:Taking the guesswork out of cancer therapy 3Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 2Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 3Health News:MonaVie Records 500th Commission Week, Having Paid Out More Than $1.4B in Distributor Commissions 2Health News:BellasDress Creates Must-have Purple Prom Dresses for Prom Attendees 2Health News:CentraComm Accepts Pure Storage Authorized Reseller Partner Invitation 2Health News:CentraComm Accepts Pure Storage Authorized Reseller Partner Invitation 3
... , ... Products at E3 Expo To Show Off Consumer Market Appeal and Wellness Benefits for Gamers ... Los Angeles, CA (Vocus) ... innovative musical instruments and music software to enable people of all ages and skill levels ...
... ... of your control environment, SAS 70 reports have become a credible marketing tool to ... ... is a leading provider that specializes solely in SAS 70 readiness reviews, SAS 70 Type ...
... promising. Sorafenib is used for advanced liver and kidney ... stem cells in pancreatic cancer. The team led by ... Molecular Oncosurgery, a group of the Department of Surgery ... W. Bchler) in cooperation with the German Cancer Research ...
... with the right information, physicians can play a stronger ... drugs proven to prevent asthma attacks, according to researchers ... finds patients are more likely to routinely take inhaled ... watch over their medication use and reviewed detailed electronic ...
... ... same-day healthcare appointments online. , ... Chicago, IL (PRWEB) June 15, 2010 -- ZocDoc, the website to ... metropolitan area. The company’s move was chosen by thousands of users, who were asked ...
... ... process should not be undertaken without legal representation, urges American Residential Law Group. ... Fort Lauderdale, FL ... foreclosure not to go through the mortgage modification process without viable legal help on ...
Cached Medicine News:Health News:Beamz Announces Partnership with Dynaflex International at E3 Expo 2Health News:Beamz Announces Partnership with Dynaflex International at E3 Expo 3Health News:Beamz Announces Partnership with Dynaflex International at E3 Expo 4Health News:Can a SAS 70 Audit Create a Competitive Advantage for Your Business? 2Health News:Can a SAS 70 Audit Create a Competitive Advantage for Your Business? 3Health News:Can a SAS 70 Audit Create a Competitive Advantage for Your Business? 4Health News:New combination effective against pancreatic cancer 2Health News:Study: Getting patients to take their asthma meds 2Health News:Chicago Votes for Improved Healthcare with ZocDoc 2Health News:American Residential Law Group Urges Homeowners Not to “Go It Alone” During Mortgage Modification 2
Galaxy Single Piece PMMA Lens with UV Absorber....
Liberty Single Piece PMMA Lens with UV Absorber....
Optical implants for the replacement of the human crystalline lens in the visual correction of aphakia....
... II is a sterile nonpyrogenic, transparent viscoelastic ... II contains 12 mg/ml of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
Medicine Products: